Analyst Reco. AxoGen, Inc.

Equities

AXGN

US05463X1063

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-08 EDT			5-day change	1st Jan Change
5.87 ^USD	+0.69%		-8.42%	-14.06%

05-02	Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024
05-02	Earnings Flash (AXGN) AXOGEN Posts Q1 Revenue $41.4M, vs. Street Est of $42.1M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Assumes AxoGen at Buy With $15 Price Target	22-11-11	MT
Cantor Fitzgerald Adjusts AxoGen Price Target to $18 From $20, Maintains Overweight Rating	22-11-08	MT
Canaccord Genuity Upgrades AxoGen to Buy from Hold, Adjusts Price Target to $15 from $10	22-05-09	MT
SVB Leerink Adjusts AxoGen's Price Target to $14 from $12, Keeps Outperform Rating	22-05-05	MT
JMP Securities Adjusts Price Target on AxoGen to $20 from $25, Keeps Market Outperform Rating	21-11-04	MT
AXOGEN : Canaccord Genuity Adjusts AxoGen PT to $24 From $21, Maintains Hold Rating	21-05-06	MT
AXOGEN : SVB Leerink Adjusts AxoGen's Price Target to $27 From $23, Keeps Outperform Rating	21-02-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW